Michael H. Davidson - Net Worth and Insider Trading

Michael H. Davidson Net Worth

The estimated net worth of Michael H. Davidson is at least $20 Million dollars as of 2024-11-13. Michael H. Davidson is the CEO of NewAmsterdam Pharma Co NV and owns about 818,563 shares of NewAmsterdam Pharma Co NV (NAMS) stock worth over $20 Million. Michael H. Davidson is also the Director of Lisata Therapeutics Inc and owns about 7,106 shares of Lisata Therapeutics Inc (LSTA) stock worth over $20,678. Details can be seen in Michael H. Davidson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael H. Davidson has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael H. Davidson

To

Michael H. Davidson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael H. Davidson owns 2 companies in total, including Lisata Therapeutics Inc (LSTA) , and Tenax Therapeutics Inc (TENX) .

Click here to see the complete history of Michael H. Davidson’s form 4 insider trades.

Insider Ownership Summary of Michael H. Davidson

Ticker Comapny Transaction Date Type of Owner
LSTA Lisata Therapeutics Inc 2020-09-09 director
TENX Tenax Therapeutics Inc 2021-02-25 director

Michael H. Davidson Latest Holdings Summary

Michael H. Davidson currently owns a total of 2 stocks. Among these stocks, Michael H. Davidson owns 818,563 shares of NewAmsterdam Pharma Co NV (NAMS) as of August 20, 2024, with a value of $20 Million and a weighting of 99.9%. Michael H. Davidson also owns 7,106 shares of Lisata Therapeutics Inc (LSTA) as of September 9, 2020, with a value of $20,678 and a weighting of 0.1%.

Latest Holdings of Michael H. Davidson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAMS NewAmsterdam Pharma Co NV 2024-08-20 818,563 24.77 20,275,806
LSTA Lisata Therapeutics Inc 2020-09-09 7,106 2.91 20,678

Holding Weightings of Michael H. Davidson


Michael H. Davidson Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael H. Davidson has made a total of 2 transactions in NewAmsterdam Pharma Co NV (NAMS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NewAmsterdam Pharma Co NV is the acquisition of 5,000 shares on August 20, 2024, which cost Michael H. Davidson around $81,350.

According to the SEC Form 4 filings, Michael H. Davidson has made a total of 1 transactions in Lisata Therapeutics Inc (LSTA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lisata Therapeutics Inc is the acquisition of 3,702 shares on September 9, 2020, which cost Michael H. Davidson around $99,945.

Insider Trading History of Michael H. Davidson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael H. Davidson Trading Performance

GuruFocus tracks the stock performance after each of Michael H. Davidson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael H. Davidson is -10.79%. GuruFocus also compares Michael H. Davidson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael H. Davidson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael H. Davidson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael H. Davidson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.78 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael H. Davidson Ownership Network

Ownership Network List of Michael H. Davidson

No Data

Ownership Network Relation of Michael H. Davidson

Insider Network Chart

Michael H. Davidson Owned Company Details

What does Lisata Therapeutics Inc do?

Who are the key executives at Lisata Therapeutics Inc?

Michael H. Davidson is the director of Lisata Therapeutics Inc. Other key executives at Lisata Therapeutics Inc include director & President & CBO David W. Slack , EVP & R&D and CMO Kristen K Buck , and CLO & SVP of Corp Dev Todd C Girolamo .

Lisata Therapeutics Inc (LSTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Lisata Therapeutics Inc (LSTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lisata Therapeutics Inc (LSTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lisata Therapeutics Inc (LSTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lisata Therapeutics Inc Insider Transactions

No Available Data

Michael H. Davidson Mailing Address

Above is the net worth, insider trading, and ownership report for Michael H. Davidson. You might contact Michael H. Davidson via mailing address: Omthera Pharmaceuticals, Inc., 707 State Road, Princeton Nj 08540.